Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bioventus (BVS) Income from Continuing Operations (2020 - 2025)

Bioventus (BVS) has disclosed Income from Continuing Operations for 6 consecutive years, with 17318000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Income from Continuing Operations rose 2971.97% year-over-year to 17318000.0, compared with a TTM value of 27274000.0 through Dec 2025, up 157.97%, and an annual FY2025 reading of 27274000.0, up 157.97% over the prior year.
  • Income from Continuing Operations was 17318000.0 for Q4 2025 at Bioventus, up from 4006000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 24528000.0 in Q2 2021 and bottomed at 101035000.0 in Q4 2022.
  • Average Income from Continuing Operations over 5 years is 13696850.0, with a median of 6114500.0 recorded in 2024.
  • The sharpest move saw Income from Continuing Operations crashed 85808.0% in 2022, then soared 2971.97% in 2025.
  • Year by year, Income from Continuing Operations stood at 25000.0 in 2021, then plummeted by 85808.0% to 21477000.0 in 2022, then soared by 60.86% to 8406000.0 in 2023, then surged by 92.83% to 603000.0 in 2024, then skyrocketed by 2971.97% to 17318000.0 in 2025.
  • Business Quant data shows Income from Continuing Operations for BVS at 17318000.0 in Q4 2025, 4006000.0 in Q3 2025, and 9272000.0 in Q2 2025.